ITGAX and neoplasm: Our isolation protocol data indicated that among tumor-infiltrating cells, 4.16 ± 0.12% were GFP-positive cells, 14.2 ± 0.34% were CD4+ cells, and 2.05 ± 0.23% were CD11c+ DCs (Figure 4A).